Company intelligence / Profile preview
Merrell
Cincinnati, Ohio, United States
- Ownership
- Private
- Employees
- ~600
- Development stage
- Other
01
Overview
Merrell/Merrell Dow developed and marketed several blockbuster drugs including Cardizem (diltiazem) for hypertension and angina; Carafate for ulcers; Seldane for allergies; Nicorette for smoking cessation. Some products were withdrawn or replaced due to safety or patent expiry issues. The company’s portfolio included both prescription and OTC medications with global approvals.
- Therapeutic areas
- GastroenterologyPsychiatryCardiovascularImmunology
- Modalities
- Small molecule
- Industry
- Pharma
02
Drug pipeline
2 assets1 more asset in the full pipeline.
03
Partnerships
Tanabe Seiyaku Co.Gensia PharmaceuticalsImmulogic Pharmaceuticals
Beyond the preview
Go deeper on Merrell.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Merrell.